Clinical Trial Update: Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on the safety of ON 01910.Na in combination with irinotecan or oxaliplatin in patients with hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Irinotecan (Irinotecan)
• ON-01910.Na (ON-01910 sodium)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Traws Pharma, Inc. | Conditions: Hepatoma, Advanced Solid Tumor | Phase 1 | Status: COMPLETED